Award Winner Interview: Adam Metherel

Can you tell us a bit about the research you did through Mitacs Elevate that led to you winning the Mitacs & NRC-IRAP Award for Commercialization?

Expanding her research horizons

Hailing from the National Autonomous University of Mexico, Daniela is stationed at the University of Saskatchewan for 12 weeks to work alongside Professor Adelaine Leung in the Department of Biomedical Sciences. Her interest in neurocognitive and neurodegenerative diseases paired perfectly with Professor Leung’s research project on depression.

A passion for medicine

Working alongside Dr. Tim Storr in Simon Fraser University’s Department of Chemistry, Laura and her team of colleagues are screening compounds that bind metals, such as zinc and copper, to look for therapeutic strategies for Alzheimer’s disease. For Laura, the hands-on research and interactive laboratory setting has been a rewarding experience. “Collaborating with my labmates has been truly inspirational. We’re tackling the project from different perspectives and sharing our methods of research.”

A path to understanding cell migration

This innovative system will allow for highly controlled quantitative data, which will provide efficient cell migration analysis. The research is important because it reveals the underlying mechanisms behind the process of wound healing and other vital cell functions.   

Song’s internship in Canada has provided him with hands-on experience that offered insight into a research field that he intends to pursue in graduate studies.

Natural healing with Kisameet clay

Found in the glacial deposit at Kisameet Bay on the British Columbia coast, the clay, now trademarked as “Kisolite”, is naturally antimicrobial.

Kisameet Glacial Clay Inc. has exclusive rights to harvest the clay for commercial use.  But the company needed solid scientific evidence of its medicinal properties prior to going to market.

Surveilling the threat of ovarian cancer

Currently, ovarian cancer is the fifth most frequent cause of cancer-related deaths for women in Western countries, largely due to its often illusive symptoms and lack of adequate screening methods.

“Participating in research on ovarian cancer has been a rewarding experience. I have learned what it means to be a researcher, what we do in the lab is for the greater good of society,” says Rebeca.

Dreams of a cure

Daniel comes to Canada from Guadalajara, Mexico’s Instituto Tecnológico y de Estudios Superiores de Monterrey’s Department of Biotechnology engineering on a 12-week Mitacs Globalink internship. Under the guidance of Dr. Peter Eck, from the Department of Human Nutritional Sciences, he is contributing to research on the genes implicated in complex chronic diseases such as Type 2 Diabetes.

Furthering cancer research through Globalink

“I was inspired by one of my colleagues at university who was part of the program last year and now promotes it in India.  I was lucky enough to be selected to come here to Canada for research into leukemia in children.”

Manish is about to begin his final year of studies for a Bachelor of Technology degree with a major in Biotechnology and a minor in Computer Science at the Indian Institute of Technology Guwahati.

Boosting stroke research through Mitacs Globalink

Severe brain damage induced by a stroke produces a reduction of immune functioning, which can result in fatal infections threatening the survival of patients after a stroke. Given that 20-25% of patients fall victim to infection post-stroke, this research is highly significant.

Research from the heart

Diego comes from Guadalajara, Mexico’s Monterrey Institute of Technology and Higher Education where he is working towards his undergraduate degree in Biotechnology. It was his initial intrigue with DNA that drove him to this field of study, but now the possibility that his research will have real world impact has pushed him to pursue his masters.

Pages